| Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress A Bernardo, P Lee, M Marcotte, MY Mian, S Rezvanian, D Sharmin, ... Neuropsychopharmacology 47 (9), 1608-1619, 2022 | 13 | 2022 |
| Rationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies LK Golani, MY Mian, T Ahmed, KP Pandey, P Mondal, D Sharmin, ... Bioorganic & Medicinal Chemistry Letters 62, 128637, 2022 | 7 | 2022 |
| Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands KP Pandey, MZA Khan, LK Golani, P Mondal, MY Mian, F Rashid, ... ARKIVOC: free online journal of organic chemistry 2020 (Pt 7), 242, 2020 | 6 | 2020 |
| Comparative anticonvulsant activity of the GABAkine KRM‐II‐81 and a deuterated analog X Ping, MJ Meyer, NM Zahn, LK Golani, D Sharmin, KP Pandey, ... Drug development research 84 (3), 601-605, 2023 | 1 | 2023 |
| GABA (A) receptor activation drives GABARAP-Nix mediated autophagy to radiosensitize primary and metastatic lung adenocarcinoma tumors D Bhattacharya, R Barrile, DK Toukam, VS Gawali, L Kallay, T Ahmed, ... Cancer Research 84 (6_Supplement), 703-703, 2024 | | 2024 |
| New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High … D Sharmin, B Divović, X Ping, R Cerne, JL Smith, S Rezvanian, P Mondal, ... ACS Chemical Neuroscience 15 (3), 517-526, 2024 | | 2024 |
| DESIGN AND SYNTHESIS OF CHIRAL AND ACHIRAL 2, 3 AND 5 SUBTYPE SELECTIVE GABA (A) REGIC LIGANDS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND DIFFERENT TYPES OF CANCERS S Rezvanian | | 2023 |
| GABA (A) receptor activation drives GABARAP-Nix mediated autophagy to radiation-sensitize primary and brain-metastatic lung adenocarcinoma tumors D Bhatacharya, R Barille, DK Toukam, VS Gawali, L Kallay, T Ahmed, ... bioRxiv, 2023.11. 29.569295, 2023 | | 2023 |
| Synthesis of analogs of KRM-II-81, gamma aminobutyric acid type A (GABAA) receptor α2/α3 subtype-selective ligand, for epilepsy treatment without any adverse effects JMC Kamal P. Pandey, Jeffrey M. Witkin, Lalit K. Golani, Md Yeunus Mian ... American Chemical Society National Meeting and Exposition-Chicago, USA …, 2022 | | 2022 |
| Synthesis and biological activity of a novel compound to treat psychological disorders and memory reduction ES Prithu Mondal, Md Yeunus Mian, Kamal P Pandey, Dishary Sharmin, Thomas D ... American Chemical Society National Meeting and Exposition-Chicago, USA …, 2022 | | 2022 |
| Positive allosteric modulation at GABAA receptor effects on symptomatic and neurotrophic in a mouse model of chronic stress JMC Sepideh Rezvanian, Prithu Mondal,Dishary Sharmin, Kamal Pandey, Md ... American Chemical Society National Meeting and Exposition-Chicago, USA …, 2022 | | 2022 |
| Synthesis and biological activity of a novel compound to treat psychological disorders and memory reduction P MONDAL, Y Mian, KP Pandey, D Sharmin, S Rezvanian, DE Knutson, ... American Chemical Society SciMeetings 3 (2), 2022 | | 2022 |
| GL-I-54, a Non-selective a2/3/5-GABAA Receptor Positive Allosteric Modulator Shows Disease Modifying Effects in Chronic Stress of Mouse Models JMC Sepideh Rezvanian1 , Farjana Rashid1, Md Yeunus Mian1, Prithu Mondal1 ... American Chemical Society National Meeting and Exposition-San Diego, USA …, 2022 | | 2022 |
| Design, synthesis, and characterization of novel analogs of clinically progressing gamma-aminobutyric acid type A (GABAA) receptor α2/α3 subtype-selective ligand KRM-II-81 for … JMC Kamal P. Pandey, Jeffrey M Witkin, Lalit K. Golani, Md Yeunus Mian ... American Chemical Society National Meeting and Exposition-San Diego, USA …, 2022 | | 2022 |
| Design, synthesis, and characterization of novel analogs of clinically progressing gamma-aminobutyric acid type A (GABAA) receptor u03b12/u03b13 subtype … KP Pandey, J Witkin, L Golani, MY Mian, P MONDAL, ... American Chemical Society SciMeetings 3 (1), 2022 | | 2022 |
| GL-I-54, a Non-selective u03b12/3/5-GABAA receptor positive allosteric modulator shows disease modifying effects in chronic stress of mouse models S Rezvanian, F Rashid, MDY MIAN, D Sharmin, P Mondal, A Bernardo, ... American Chemical Society SciMeetings 3 (1), 2022 | | 2022 |
| Synthesis and Analysis of the Anti-depressant Activity of GL-I-54, a Positive Allosteric GABAA Receptor Modulator S Rezvanian, F Rashid, MY Mian, P Mondal, D Sharmin, K Panday, ... ACS Milwaukee Fall Poster Session, 2021 | | 2021 |
| Synthesis of Chiral Imidazodiazepines as a-Subtype Selective GABA(A) R Modulators to Treat Schizophrenia and Depression S Rezvanian, G Li, F Rashid, JM Cook University of Wisconsin Milwaukee Chemistry Department Symposium Spring 2021, 2021 | | 2021 |
| An efficient debromination technique using PMHS with a number of ligands containing different functional groups MY Mian, P Mondal, D Sharmin, KP Pandey, F Rashid, S Rezvanian, ... Arkivoc, 171-188, 2021 | | 2021 |
| Treatment of psychological disorders with GABAA alpha-5 positive allosteric modulator JMC Etienne Sibille Prithu Mondal, Md Yeunus Mian, Kamal P Pandey, Dishary ... ACS MILWAUKEE FALL CONFERENCE 2021, 2021 | | 2021 |
Dishary SharminGraduate Teaching and Research AssistantVerified email at uwm.edu
